Astron
Biotronik AG · Decision date Dec 17, 2025
What did the FDA decide?
FDA records P140030/S022 as a supplement to PMA P140030, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 17, 2025.
FDA approval order statement
new hydrogen content testing equipment
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 17, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P140030/S022
- Regulatory pathway
- PMA supplement
- Applicant
- Biotronik AG
- Product code
- NIO
- Decision code
- OK30
- Decision date
- Dec 17, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Biotronik AG
- Product code
- NIO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140030. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140030 · Original PMA
ASTRON PERIPHERAL SELF-EXPANDING NITINOL STENT SYSTEM
P140030/S021 · Related supplement
Astron Peripheral Self- Expanding Nitinol Stent System
P140030/S022 received
Application receipt date recorded by FDA.
P140030/S022 · FDA decision
30-Day Notice
P140030/S024 · Related supplement
Astron Peripheral Self-Expanding Nitinol Stent System
P140030/S025 · Related supplement
Astron Peripheral Self-Expanding Nitinol Stent System
Timeline entries are records held by MedtechLedger for P140030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biotronik AG | PMA approval | Dec 17, 2015 | FDA | |
AstronP140030/S019 | Biotronik AG | PMA supplement | Jul 16, 2025 | FDA |
| Biotronik AG | PMA supplement | Oct 21, 2025 | FDA | |
AstronP140030/S023 | Biotronik AG | PMA supplement | Mar 10, 2026 | FDA |
| Biotronik AG | PMA supplement | Jun 22, 2026 | FDA | |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
Epic Vascular Self-Expanding Stent SystemP110035/S079 | Boston Scientific Corp | PMA supplement | Aug 21, 2026 | FDA |
Epic Vascular Self-Expanding Stent SystemP110035/S078 | Boston Scientific Corp | PMA supplement | Aug 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biotronik AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ackerstrasse 6, Bülach, 8180
Sources and methodology
- Original FDA record: P140030/S022
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





